A Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease
Status:
Active, not recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Objective of this study is to investigate the safety, pharmacokinetics and efficacy of
KDT-3594 in patients with early Parkinson's disease without a concomitant medication of
L-dopa.